Impact of Capillaroscopy in the Investigation of Diffuse Interstitial Pneumonias
Recruiting
N/A
Interventional Study
Interstitial Lung Disease
Connective Tissue Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 48 (estimated)
- Sponsor
- University Hospital, Bordeaux · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The investigators hypothesize that in patients with a new diagnosis of Pulmonary Interstitial Disease (PID), adding capillaroscopy to standard care increases the proportion of patients receiving a diagnosis of PID-Connective Tissue Disease (PID-CTD) within the first three months of follow-up, thereby reducing the time to diagnosis and facilitating the implementation of appropriate treatment as qui…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male or female over 18 years of age;
* Have received a new diagnosis of PID within the last six months, confirmed by a pulmonologist;
* Have undergone some specific tests within the last six months (Chest CT scan, respiratory function tests (plethysmography and CO transfer cap…
Contacts